NAGE
Niagen Bioscience, Inc.
NASDAQ: NAGE · CONSUMER DEFENSIVE · PACKAGED FOODS
$2.54
+1.60% today
Updated 2026-10-28
Market cap
$197.02M
P/E ratio
13.11
P/S ratio
1.54x
EPS (TTM)
$0.19
Dividend yield
—
52W range
$2 – $8
Volume
0.5M
Niagen Bioscience, Inc. (NAGE) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$2.54
12-Month target
$3.62
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 13.11x (capped 25x) · Margin: 12.40%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.